Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B Infection

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2021
This is a randomized, open label, multicenter Phase 2 study investigating the safety and antiviral activity of AB-729 in combination with ongoing NA therapy and short courses of Peg-IFNα-2a in subjects with CHB.
Epistemonikos ID: 084a12a00cdf5467bdd338d78e2f226baac4e415
First added on: Nov 24, 2021